Blood test may help identify which colorectal cancer patients most likely to benefit from chemotherapy after surgery. A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers Congress 2026.
- Ponto de atenção: blood.
- Ponto de atenção: test.
- Ponto de atenção: help.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
